Skip to Content
Merck
  • High throughput quantification of prohibited substances in plasma using thin film solid phase microextraction.

High throughput quantification of prohibited substances in plasma using thin film solid phase microextraction.

Journal of chromatography. A (2014-12-03)
Nathaly Reyes-Garcés, Barbara Bojko, Janusz Pawliszyn
ABSTRACT

Simple, fast and efficient sample preparation approaches that allow high-throughput isolation of various compounds from complex matrices are highly desired in bioanalysis. Particularly sought are methods that can, without sacrificing time, easily remove matrix interferences capable of inducing ionization suppression/enhancement, or causing detrimental effects in instrumental performance. In this work, an automated high-throughput sample preparation method using thin film solid phase microextraction (SPME) for the analysis of multiple prohibited substances in plasma is proposed. A biocompatible SPME extraction phase made of hydrophilic-lipophilic balance particles immobilized with polyacrylonitrile (PAN) demonstrated satisfactory extraction capabilities for 25 compounds of a wide range of polarities (logP from -2 to 6.8). Due to the well-known biocompatible characteristics of PAN-based SPME coatings, minimum sample handling was required. Experimental conditions for pre-conditioning, extraction, wash and desorption were carefully optimized for the proposed method. By taking full advantage of the 96 thin film handling capability of the automated system, a preparation time of approximately 1.5min per sample can be achieved. Satisfactory results in terms of absolute matrix effects were found for the majority of the studied analytes, given that 24 out of 25 compounds exhibited values in the range of 100 and 120%. The method was validated in terms of linearity (R(2)>0.99), inter and intra-day accuracy (85-130%) and precision (<20%) and limits of quantitation (0.25-10ngmL(-1) for most compounds).

MATERIALS
Product Number
Brand
Product Description

Supelco
Salbutamol, VETRANAL®, analytical standard
Sigma-Aldrich
Dexamethasone, powder, BioReagent, suitable for cell culture, ≥97%
Furosemide, European Pharmacopoeia (EP) Reference Standard
USP
Furosemide, United States Pharmacopeia (USP) Reference Standard
Furosemide for peak identification, European Pharmacopoeia (EP) Reference Standard
USP
Dexamethasone, United States Pharmacopeia (USP) Reference Standard
Dexamethasone, British Pharmacopoeia (BP) Assay Standard
Salbutamol, European Pharmacopoeia (EP) Reference Standard
Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard
Prednisolone for peak identification, European Pharmacopoeia (EP) Reference Standard
Dexamethasone, European Pharmacopoeia (EP) Reference Standard
Nikethamide, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Formic acid, reagent grade, ≥95%
Sigma-Aldrich
Potassium phosphate monobasic, powder, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
Potassium phosphate monobasic, ACS reagent, ≥99.0%
Supelco
Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Formic acid, ≥95%, FCC, FG
Sigma-Aldrich
Furosemide
Sigma-Aldrich
Sodium phosphate dibasic, ACS reagent, ≥99.0%
Sigma-Aldrich
Sodium phosphate dibasic, ReagentPlus®, ≥99.0%
USP
Monobasic potassium phosphate, United States Pharmacopeia (USP) Reference Standard
Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard
Prednisolone, British Pharmacopoeia (BP) Assay Standard
Sigma-Aldrich
Potassium chloride, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
Codeine, European Pharmacopoeia (EP) Reference Standard
Prednisolone, European Pharmacopoeia (EP) Reference Standard
Prednisolone for system suitability, European Pharmacopoeia (EP) Reference Standard
Stanozolol, European Pharmacopoeia (EP) Reference Standard
USP
Prednisolone, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
N,N-Dimethylformamide, anhydrous, 99.8%